Skip to main content

Advertisement

SpringerLink
Log in

Leukemia and the nervous system

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Leukemia affects the central and peripheral nervous system. Neurologic complications are a consequence of direct leukemic infiltration, as occurs with leukemic meningitis, and due to complications of either antileukemic treatment (thrombocytopenic or disseminated intravascular coagulation-related intracranial hemorrhage, steroid myopathy, vinca alkaloid peripheral neuropathy) or immune compromise (Herpes zoster shingles or Aspergillus meningitis).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Xie Y, Davies SM, Xiang Y, et al.: Trends in leukemia incidence and survival in the United States (1973–1998), 9:2229–2235.

  2. Hoelzer D, Gokbuget N, Ottmann O, et al.: Acute lymphoblastic leukemia. Hematology 2002, 1:162–171.

    Article  Google Scholar 

  3. Pui C-H, Evans WE: Acute lymphoblastic leukemia. Drug Ther 9:605–615.

  4. Recht L, Mrugala M: Neurologic complications of hematologic neoplasms. Neurol Clin 2003, 21:87–105. A excellent review of neurologic complications in patients with hematologic malignancies.

    Article  PubMed  Google Scholar 

  5. Meyer RJ, Ferreira, PP, Cuttner J, et al.: Central nervous system involvement at presentation in acute granulocytic leukemia: a Prospective Cytocentrifuge Study. Am J Med 1980, 68:691–694.

    Article  PubMed  CAS  Google Scholar 

  6. Teshima T, Akashi K, Shibuka T, et al.: Central nervous system involvement in adult T-cell leukemia/lymphoma. Cancer 1990, 65:327–332.

    Article  PubMed  CAS  Google Scholar 

  7. Kim H, Lee J-H, Choi S-J, et al.: Analysis of fatal intracranial hemorrhage in 792 acute leukemia patients. Haematologica 2004, 89:622–624.

    PubMed  Google Scholar 

  8. Kawanami T, Kurita K, Yamakawa M, et al.: Cerebrovascular disease in acute leukemia: a clinicopathological study of 14 patients. Intern Med 2002, 41:1130–1134.

    PubMed  Google Scholar 

  9. Sostak P, Padovan CS, Yousry TA, et al.: Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 2003, 60:842–848.

    PubMed  CAS  Google Scholar 

  10. Bower JH, Hammack JE, McDonnell SK, Tefferi A: The neurologic complications of B-cell chronic lymphocytic leukemia. Neurology 1997, 48:407–412.

    PubMed  CAS  Google Scholar 

  11. Cramer SC, Glaspy JA, Efird JT, Louis DN: Chronic lymphocytic leukemia and the central nervous system: a clinical and pathological study. Neurology 1996, 46:19–25.

    PubMed  CAS  Google Scholar 

  12. Plotkin SR, Wen PY. Neurologic complications of cancer therapy. Neurol Clin 2003, 21:279–318. An excellent review of neurologic complications resulting from cancer treatment and, in particular, chemotherapy.

    Article  PubMed  Google Scholar 

  13. Cortes J: Central nervous system involvement in adult acute lymphocytic leukemia. Hematol Oncol Clin North Am 2001, 15:145–162.

    Article  PubMed  CAS  Google Scholar 

  14. Wolk RW, Masse SR, Conklin R, Freireich EJ: The incidence of central nervous system leukemia in adults with acute leukemia. Cancer 1974, 33:863–871.

    Article  PubMed  CAS  Google Scholar 

  15. Stewart DJ, Keating MJ, McCredie KB, et al.: Natural history of central nervous system acute leukemia in adults. Cancer 1981, 47:184–196.

    Article  PubMed  CAS  Google Scholar 

  16. Chen C-Y, Zimmerman RA, Faro S, et al.: Childhood leukemia: central nervous system abnormalities during and after treatment. AJNR Am J Neuroradiol 1996, 17:295–310.

    PubMed  CAS  Google Scholar 

  17. Surapaneni UR, Cortes JE, Thomas D, et al.: Central nervous system relapse in adults with acute lymphoblastic leukemia. Cancer 2002, 94:773–780. The best summary of outcome in adult patients with leukemic meningitis treated at a single institution.

    Article  PubMed  Google Scholar 

  18. Cash J, Fehir KM, Pollack MS: Meningeal involvement in early stage chronic lymphocytic leukemia. Cancer 1987, 59:798–800.

    Article  PubMed  CAS  Google Scholar 

  19. Dekker AW, Elderson A, Punt K, Sixma JJ: Meningeal involvement in patients with acute nonlymphocytic leukemia. Cancer 1985, 56:2078–2082.

    Article  PubMed  CAS  Google Scholar 

  20. Kaplan JG, DeSouza TG, Farkash A, et al.: Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 1990, 9:225–229.

    Article  PubMed  CAS  Google Scholar 

  21. Chamberlain M: Leptomeningeal metastases. In Cancer in the Nervous System. Edited by Levin V. New York: Churchill Livingstone; 1996:282–290.

    Google Scholar 

  22. Grossman SA, Krabak MJ: Leptomeningeal carcinomatosis. Cancer Treat Rev 1999; 25, 2:103–119.

    Article  PubMed  CAS  Google Scholar 

  23. Chamberlain MC: Leptomeningeal metastases: a review of evaluation and treatment. J Neurooncol 1998, 37:271–284.

    Article  PubMed  CAS  Google Scholar 

  24. Kantarjian HM, Walters RS, Smith TL, et al.: Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia. Blood 1988, 72:1784–1789.

    PubMed  CAS  Google Scholar 

  25. Kantarjian HM, Smith T, Estey E, et al.: Prognostic significance of elevated serum beta 2-microglobulin levels in acute lymphocytic leukemia. Am J Med 1992, 93:599–604.

    Article  PubMed  CAS  Google Scholar 

  26. Ravandi F, Cortes J, Estrov Z, et al.: CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia. Leuk Res 2002, 26:643–649.

    Article  PubMed  CAS  Google Scholar 

  27. Kantarijian HM, O’Brien S, Smith TL, et al.: Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000, 18:547–561.

    Google Scholar 

  28. Mavlight GM, Stuckey SE, Cabanillas FF, et al.: Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination. N Engl J Med 1980, 303:718–722.

    Article  PubMed  CAS  Google Scholar 

  29. Kersten MJ, Evers LM, Dellemijn PL, et al.: Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies. Blood 1996, 87:1985–1999.

    PubMed  CAS  Google Scholar 

  30. Burger B, Zimmermann M, Mann G, et al.: Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 2003, 21:184–188.

    Article  PubMed  Google Scholar 

  31. Wasserstrom W, Glass J, Posner J: Diagnosis and treatment of leptomeningeal metastases from solid tumors experience with 90 patients. Cancer 1982, 49:759–772.

    Article  PubMed  CAS  Google Scholar 

  32. Van Oostenbrugge RJ, Twijnstra A: Presenting features and value of diagnostic procedures in leptomeningeal metastases. Neurology 1999, 53:382–385.

    PubMed  Google Scholar 

  33. Wasserstrom WR, Schwartz MK, Fleisher M, et al.: Cerebrospinal fluid biochemical markers in central nervous system tumors: a review. Ann Clin Lab Sci 1981, 11:239–251.

    PubMed  CAS  Google Scholar 

  34. Van Zanten AP, Twijnstra A, Hart AA, et al.: Cerebrospinal fluid lactate dehydrogenase activities in patients with central nervous system metastases. Clin Chim Acta 1986, 161:259–268.

    Article  PubMed  Google Scholar 

  35. Klee GG, Tallman RD, Goellner JR, et al.: Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis. Mayo Clin Proc 1986, 61:9–13.

    PubMed  CAS  Google Scholar 

  36. Twijnstra A, van Zanten AP, Hart AA, et al.: Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours. J Neurol Neurosurg Psychiatry 1987, 50:313–320.

    Article  PubMed  CAS  Google Scholar 

  37. Twijnstra A, Ongerboerd, V, van Zanten AP, et al.: Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors. J Neurooncol 1989, 7:57–63.

    Article  PubMed  CAS  Google Scholar 

  38. Chamberlain MC: Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers. Neurology 1998, 50:1173–1175.

    PubMed  CAS  Google Scholar 

  39. Garson JA, Coakham HB, Kemshead JT, et al.: The role of monoclonal antibodies in brain tumour diagnosis and cerebrospinal fluid (CSF) cytology. J Neurooncol 1985, 3:165–171.

    Article  PubMed  CAS  Google Scholar 

  40. Boogerd W, Vroom TM, van Heerde P, et al.: CSF cytology versus immunocytochemistry in meningeal carcinomatosis. J Neurol Neurosurg Psychiatry 1988, 51:142–145.

    PubMed  CAS  Google Scholar 

  41. Van Oostenbrugge RJ, Hopman AH, Ramaekers FC, et al.: In situ hybridization: a possible diagnostic aid in leptomeningeal metastasis. J Neurooncol 1998, 38:127–133.

    Article  PubMed  Google Scholar 

  42. Cibas ES, Malkin MG, Posner JB, et al.: Detection of DNA abnormalities by flow cytometry in cells from cerebrospinal fluid. Am J Clin Pathol 1987, 88:570–577.

    PubMed  CAS  Google Scholar 

  43. Biesterfeld S, Bernhard B, Bamborschke S, et al.: DNA single cell cytometry in lymphocytic pleocytosis of the cerebrospinal fluid. Acta Neuropathol (Berl) 1993, 86:428–432.

    CAS  Google Scholar 

  44. Van Oostenbrugge RJ, Hopman AH, Arends JW et al.: The value of interphase cytogenetics in cytology for the diagnosis of leptomeningeal metastases. Neurology 1998, 51:906–908.

    PubMed  Google Scholar 

  45. Chamberlain M, Sandy A, Press G: Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrastenhanced CT of the brain. Neurology 1990, 40:435–438.

    PubMed  CAS  Google Scholar 

  46. Gomori JM, Heching N, Siegal T: Leptomeningeal metastases: evaluation by gadolinium enhanced spinal magnetic resonance imaging. J Neurooncol 1998, 36:55–60.

    Article  PubMed  CAS  Google Scholar 

  47. Sze G, Soletsky S, Bronen R, et al.: MR imaging of the cranial meninges with emphasis on contrast enhancements and meningeal carcinomatosis. AJNR Am J Neuroradiol 1989, 10:965–975.

    PubMed  CAS  Google Scholar 

  48. Chamberlain MC: Comparative spine imaging in leptomeningeal metastases. Neuro-Oncol 1995, 23:233–238.

    Article  CAS  Google Scholar 

  49. Kramer E, Rafto S, Packer R, et al.: Comparison of myelography with CT follow-up versus gadolinium MRI for subarachnoid metastatic disease in children. Neurology 1991, 41:46–50.

    PubMed  CAS  Google Scholar 

  50. Chamberlain M, Corey-Bloom J: Leptomeningeal metastases Indium-DTPA CSF flow studies. Neurology 1991, 41:1765–1769.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Southern California, Norris Comprehensive Cancer Center and Hospital, 1441 Eastlake Avenue, Room 3459, 90033, Los Angeles, CA, USA

    Marc C. Chamberlain MD

Authors
  1. Marc C. Chamberlain MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chamberlain, M.C. Leukemia and the nervous system. Curr Oncol Rep 7, 66–73 (2005). https://doi.org/10.1007/s11912-005-0028-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-005-0028-7

Keywords

Search

Navigation